Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 5, 2026
Medite Cancer Diagnostics Market Cap
Medite Cancer Diagnostics has a market cap or net worth of $8.58 thousand as of October 9, 2026. It is the 51,825th most valuable company in the world and the 7,859th biggest in the United States.
Market Cap
8.58K
Enterprise Value
n/a
Revenue
8.13M
Global Rank
Country Rank
#7,859 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 1998, Medite Cancer Diagnostics's market cap has decreased from 591.70K to 8.58K, a decrease of -98.55%. That is a compound annual growth rate of -14.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 8.58K | -98.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnerScope Hearing Technologies | 152.75K |
| LifePoint | 30.63K |
| Remedent | 15.42K |
| Medical International Technology | 8.43K |
| BioLife Sciences | 4.83K |
| OJsys | 3.50K |
| Paradigm Medical Industries | 3.25K |
| SheerVision | 2.55K |